These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1100 related articles for article (PubMed ID: 29651130)

  • 1. Targeting the tumour stroma to improve cancer therapy.
    Valkenburg KC; de Groot AE; Pienta KJ
    Nat Rev Clin Oncol; 2018 Jun; 15(6):366-381. PubMed ID: 29651130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the host stroma in cancer and its therapeutic significance.
    Tarin D
    Cancer Metastasis Rev; 2013 Dec; 32(3-4):553-66. PubMed ID: 23625010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the tumor stroma for cancer therapy.
    Xu M; Zhang T; Xia R; Wei Y; Wei X
    Mol Cancer; 2022 Nov; 21(1):208. PubMed ID: 36324128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The conflicting roles of tumor stroma in pancreatic cancer and their contribution to the failure of clinical trials: a systematic review and critical appraisal.
    Bijlsma MF; van Laarhoven HW
    Cancer Metastasis Rev; 2015 Mar; 34(1):97-114. PubMed ID: 25566685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
    Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
    Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the tumor microenvironment: from understanding pathways to effective clinical trials.
    Fang H; Declerck YA
    Cancer Res; 2013 Aug; 73(16):4965-77. PubMed ID: 23913938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The bad seed: Cancer stem cells in tumor development and resistance.
    Koren E; Fuchs Y
    Drug Resist Updat; 2016 Sep; 28():1-12. PubMed ID: 27620951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of therapies targeting tumor vasculature and stroma.
    Davis ID; Desai J
    Curr Cancer Drug Targets; 2008 Sep; 8(6):498-508. PubMed ID: 18781896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting tumor-stroma crosstalk: the example of the NT157 inhibitor.
    Rampias T; Favicchio R; Stebbing J; Giamas G
    Oncogene; 2016 May; 35(20):2562-4. PubMed ID: 26477311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor-stromal interactions in lung cancer: novel candidate targets for therapeutic intervention.
    El-Nikhely N; Larzabal L; Seeger W; Calvo A; Savai R
    Expert Opin Investig Drugs; 2012 Aug; 21(8):1107-22. PubMed ID: 22667993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies of targeting pathological stroma for enhanced antitumor therapies.
    Zhu Y; Yu F; Tan Y; Yuan H; Hu F
    Pharmacol Res; 2019 Oct; 148():104401. PubMed ID: 31422113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal Cells in the Tumor Microenvironment.
    Denton AE; Roberts EW; Fearon DT
    Adv Exp Med Biol; 2018; 1060():99-114. PubMed ID: 30155624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complexity in the tumour microenvironment: Cancer associated fibroblast gene expression patterns identify both common and unique features of tumour-stroma crosstalk across cancer types.
    Gandellini P; Andriani F; Merlino G; D'Aiuto F; Roz L; Callari M
    Semin Cancer Biol; 2015 Dec; 35():96-106. PubMed ID: 26320408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of tumor-stromal fibroblast interactions: implications in anticancer therapy.
    Kiaris H; Trimis G; Papavassiliou AG
    Curr Med Chem; 2008; 15(29):3062-7. PubMed ID: 19075653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in tumor stroma-based targeted delivery.
    Wu C; Zhai Y; Ji J; Yang X; Ye L; Lu G; Shi X; Zhai G
    Int J Pharm; 2024 Oct; 664():124580. PubMed ID: 39142464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic reprogramming of the tumour microenvironment.
    Xing Y; Zhao S; Zhou BP; Mi J
    FEBS J; 2015 Oct; 282(20):3892-8. PubMed ID: 26255648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fighting the force: Potential of homeobox genes for tumor microenvironment regulation.
    Northcott JM; Northey JJ; Barnes JM; Weaver VM
    Biochim Biophys Acta; 2015 Apr; 1855(2):248-53. PubMed ID: 25818365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast tumor stroma: A driving force in the development of resistance to therapies.
    Majidinia M; Yousefi B
    Chem Biol Drug Des; 2017 Mar; 89(3):309-318. PubMed ID: 28042683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of In Vitro Co-Culture Model in Anti-Cancer Drug Development Cascade.
    Xu R; Richards FM
    Comb Chem High Throughput Screen; 2017; 20(5):451-457. PubMed ID: 28155598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug delivery.
    Bouzin C; Feron O
    Drug Resist Updat; 2007 Jun; 10(3):109-20. PubMed ID: 17452119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.